Skip to content

Cross-Sectional Survey on the Use of Tobacco Products - Germany

Cross-Sectional Survey on the Use of Tobacco Products in the General Population and in Users of IQOS in Germany (2018-2020)

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03527017
Enrollment
6284
Registered
2018-05-16
Start date
2018-03-12
Completion date
2020-02-24
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use

Keywords

Tobacco Use, IQOS

Brief summary

The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Germany.

Detailed description

The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of Germany and in adult IQOS users registered in the IQOS user database of Philip Morris GmbH (Germany IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are: 1. Estimate the prevalence of current tobacco use status in the study population. 2. Describe the past tobacco use status (cigarette, IQOS and other innovative products, including e-cigarettes) in the study population (i.e. never-use, initiation, product use transition, cessation, re-initiation, and relapse). 3. Explore the association between self-reported health status and use of tobacco products in the study population. 4. Explore the association between patterns of use (including misuse) with motivation to use, perceived quality attributes of IQOS (e.g. risk and self-reported changes since switching to the product, in a number of relevant domains where IQOS may have potential benefits), and consumer's satisfaction in the population of IQOS users in Germany registered in the Germany IQOS User Database.

Interventions

Face-to-face survey to estimate the prevalence of current tobacco use status in the general population of Germany.

Online survey to describe patterns of use in adult IQOS users residing in Germany.

Sponsors

Philip Morris Products S.A.
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

(all participants, including IQOS users): * Legally permitted to buy tobacco products in Germany (≥18 years of age). * Currently residing in Germany. * Able to read, write and understand German. * Consent to participate in the survey Inclusion Criteria (IQOS users only): * Has used more than 100 HEETS tobacco sticks in his or her lifetime. * Is currently using IQOS. * Has access to the internet. * Is not currently employed by Philip Morris International or any of its affiliates

Exclusion criteria

* Not meeting the inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of current tobacco useStudy duration (3 years).Prevalence of current tobacco use status in the study population.
Past tobacco use statusStudy duration (3 years).Past tobacco use status (cigarette, IQOS and other innovative products) in the study population.
Self-reported health statusStudy duration (3 years).Association between self-reported health status and use of tobacco products in the study population.
Perceived riskStudy duration (3 years).Association between patterns of use with perceived risk.
IQOS use experienceStudy duration (3 years).Describe the IQOS user experience, including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of domains where IQOS may have potential benefits).

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026